BI 764198: TRPC6 inhibitor Indication: Focal Segmental Glomerulosclerosis This compound is under investigation, further information will be available soon. Anchored in external partnership or acquisition Partnering inquiries Join our team Additional links Innovation in Cardio-Renal-Metabolic Diseases Metabolic Diseases Partnering in CardioMetabolic Diseases
